Mirae Asset Global Investments Co., Ltd. Merus N.V. Transaction History
Mirae Asset Global Investments Co., Ltd.
- $20 Billion
- Q2 2024
A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Merus N.V. stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 1,978 shares of MRUS stock, worth $99,097. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,978Holding current value
$99,097% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding MRUS
# of Institutions
188Shares Held
59MCall Options Held
345KPut Options Held
222K-
Rtw Investments, LP New York, NY4.17MShares$209 Million4.12% of portfolio
-
Commodore Capital LP New York, NY3.2MShares$160 Million16.98% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY2.75MShares$138 Million3.41% of portfolio
-
Federated Hermes, Inc. Pittsburgh, PA2.4MShares$120 Million0.34% of portfolio
-
Samlyn Capital, LLC New York, NY2.32MShares$116 Million2.45% of portfolio
About Merus N.V.
- Ticker MRUS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,878,200
- Market Cap $2.3B
- Description
- Merus N.V., a clinical-stage immuno-oncology company, engages in the discovery and development of bispecific antibody therapeutics in the Netherlands. Its bispecific antibody candidate pipeline includes Zenocutuzumab (MCLA-128), which is in a phase 2 clinical trials for the treatment of patients with metastatic breast cancer, as well as in Phase...